Correction to: Enhanced chemotherapy response in hepatocellular carcinoma: synergistic effects of miR-122 and doxorubicin co-delivery system inducing apoptosis and DNA damage (Cancer Nanotechnology, (2024), 15, 1, (48), 10.1186/s12645-024-00287-x)

Abstract

In this article the affiliation details for authors were incorrectly given as “Department of Hepatopancreatobiliary Medical Oncology, Fujian Cancer Hospital, Clinical Oncology School of Fujian Medical University, Fuzhou, Fujian, People’s Republic of China” but should have been Department of Hepatopancreatobiliary Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, P. R. China. The original article has been corrected.